Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVRA Patch User Experience in Europe
NCT00261482Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2003
- Modality
- Transdermal Patches, Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of ethinyl estradiol + norelgestromin in contraception, sponsored by Janssen Pharmaceutical. Primary endpoint: Level of satisfaction with EVRA at Cycle 6. Started Jul 2003; status: completed.
02
Drugs
ethinyl estradiol + norelgestromin
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00261482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00261482.